drugset / Trial / NCT06042738

Investigation of The Effectiveness of Antioxidant Therapy in Oligoasthenoteratozoospermic Infertile Men

NCT06042738

Completed 48 enrolled Ondokuz Mayıs University
RandomizedParallel-groupDouble-blindSupportive care

Summary

Approximately 30% of the factors that cause male infertility are due to idiopathic causes. Increased reactive oxygen species (ROS) due to many known and unknown factors cause male infertility by affecting spermatogenesis and sperm maturation. In this study, the effects of physical activity and antioxidant food supplementation on seminal antioxidant capacity, sperm DNA fragmentation index, sperm chromatin quality and sperm parameters were investigated in infertile cases.

Timeline

Start
2021-03-01
Primary completion
2021-11-01
Completion
2021-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetylcarnitine Small molecule 932 mg
Subject Coenzyme Q10 Other / unclassified 50 mg
Subject Fructose Small molecule 2000 mg
Subject L-carnitine Other / unclassified 2000 mg
Subject Selenium Other / unclassified 115 ug
Subject Vitamin B12 Other / unclassified 3750 ug
Subject Vitamin C Other / unclassified 225 mg
Subject Zinc Sulfate Unknown 14 mg
Subject citric acid Unknown 115 mg
Subject folic acid Other / unclassified 500 ug

Indications